Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

Clinical trial NCT07471503 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07471503
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis (MF)HSCT

Start date: 2026-03-16
Primary completion: 2029-04-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.